Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2008 (Vol. 28, No. 1)

BioMarket Trends: Orphan Drug Arena Driven by Biologics

Entry of Biogenerics Will Radically Alter Market that Is Mainstay of Some Biotech Firms

  • An orphan drug can be defined as a product that treats a rare disease, although different countries have slightly different definitions. For example, the FDA defines a rare disease as a disease with an incidence of less than 1:5,000 of the general population, while the European Union defines it ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.